1. Allison RR, Schulsinger A, Vongtama V, Barry T, Shin KH. Radiation and chemotherapy improve outcome in oligodendroglioma. IJROBP. 1997;37(2):399-403.
2. Karim AB, Afra D, Cornu P, Bleehan N, Schraub S, De Witte O, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. IJROBP. 2002;52(2):316-24.
3. Ellis TL, Stieber VW, Austin RC. Oligodendroglioma. Curr Treat Options Oncol. 2003;4(6):479-90.
4. Engelhard HH, Stelea A, Mundt A. Oligodendroglioma and anaplastic oligodendroglioma:: Clinical features, treatment, and prognosis. Surg Neurol. 2003;60(5):443-56.
5. Van den Bent M, Taphoorn M, Brandes Aa, Menten J, Stupp R, Frenay M, et al. Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971. J Clin Oncol. 2003;21(13):2525-8.
6. Fleury A, Menegoz F, Grosclaude P, Daures JP, Henry‐Amar M, Raverdy N, et al. Descriptive epidemiology of cerebral gliomas in France. Cancer. 1997;79(6):1195-202.
7. Van den Bent M. Advances in the biology and treatment of oligodendrogliomas. Curr Opin Neurol. 2004;17(6):675-80.
8. Hashimoto N, Murakami M, Takahashi Y, Fujimoto M, Inazawa J, Mineura K. Correlation between genetic alteration and long‐term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p. Cancer. 2003;97(9):2254-61.
9. Jacob R, Jyothirmayi R, Dalal Y, Nambiar U, Rajan B, Nair M. Oligodendroglioma: clinical profile and treatment results. Neurol India. 2002;50(4):462.
10. HELSETH A, MØRK SJ, JOHANSEN A, TRETLI S. Neoplasms of the central nervous system in Norway. APMIS. 1989;97(7‐12):646-54.
11. Nutt CL, Mani D, Betensky RA, Tamayo P, Cairncross JG, Ladd C, et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res. 2003;63(7):1602-7.
12. Peterson K, Cairncross JG. Oligoden-droglioma. Cancer Invest. 1996;14(3):243-51.
13.Kleihues P, Cavenee WK. Pathology and genetics of tumours of the nervous system: International Agency for Research on Cancer; 2000.
14.Celli P, Nofrone I, Palma L, Cantore G, Fortuna A. Cerebral oligodendroglioma: prognostic factors and life history. Neurosurgery. 1994;35(6):1018-35.
15. Daumas-Duport C, Varlet P, Tucker M-L, Beuvon F, Cervera P, Chodkiewicz J-P. Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J Neurooncol. 1997;34(1):37-59.
16.Engelhard HH, Stelea A, Cochran EJ. Oligodendroglioma: pathology and molecular biology. Surg Neurol. 2002;58(2):111-7.
17. Paleologos NA, Cairncross JG. Treatment of oligodendroglioma: an update. Neuro Oncol. 1999;1(1):61-8.
18.Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97-109.
19.Feigenberg SJ, Amdur RJ, Morris CG, Mendenhall WM, Marcus Jr RB, Friedman WA. Oligodendroglioma: does deferring treatment compromise outcome? Am J Clin Oncol. 2003;26(3):e60-e6.
20.Fortin D, Cairncross GJ, Hammond RR. Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment. Neurosurgery. 1999;45(6):1279.
21.Sunyach M, Pommier P, Lafay IM, Guyotat J, Ginestet G, Jouanneau E, et al. Conformal irradiation for pure and mixed oligodendroglioma: the experience of Centre Leon Berard Lyon. IJROBP. 2003;56(1):296-303.
22. Shaw EG, Scheithauer BW, O'Fallon JR, Tazelaar HD, Davis DH. Oligodendrogliomas: the Mayo clinic experience. J Neurosurg. 1992;76(3):428-34.
23. SPSS I. IBM SPSS statistics 22. Algorithms Chicago: IBM SPSS Inc. 2013.
24. Nielsen MS, Christensen HC, Kosteljanetz M, Johansen C. Incidence of and survival from oligodendroglioma in Denmark, 1943–2002. Neuro Oncol. 2009;11(3):311-7.
25. Mørk SJ, Lindegaard K-F, Halvorsen TB, Lehmann EH, Solgaard T, Hatlevoll R, et al. Oligodendroglioma: incidence and biological behavior in a defined population. J Neurosurg. 1985;63(6):881-9.
26. Chin HW, Hazel JJ, Kim TH, Webster JH. Oligodendrogliomas I. A clinical study of cerebral oligodendrogliomas. Cancer. 1980;45(6):1458-66.
27.Reyes-Botero G, Mokhtari K, Martin-Duverneuil N, Delattre J-Y, Laigle-Donadey F. Adult brainstem gliomas. The oncologist. 2012;17(3):388-97.